Situaciones de broncoespasmo, obstrucción de las vías aéreas superiores, hipersecreción bronquial y determinadas características de los circuitos externos del. Contraindicada en casos de hipersensibilidad a la levodropropizina o compuestos estructuralmente relacionados, hipersecreción bronquial o función. Se asocia a: Hiperreactividad bronquial con episodios recurrentes de sibilancias, disnea, opresión torácica y tos. Obstrucción bronquial difusa.
|Published (Last):||27 July 2015|
|PDF File Size:||16.88 Mb|
|ePub File Size:||18.77 Mb|
|Price:||Free* [*Free Regsitration Required]|
Monografías de Archivos de Bronconeumología
Brain B, et al. Steinfort DP, Steinfort C. No adverse events were reported with acebrophylline. A genome-wide association study of bronchodilator response in asthmatics. Safety and tolerability of medication were also evaluated. J Allergy Clin Immunol.
Long-term treatment benefits with tiotropium in COPD patients with brnoquial without short-term bronchodilator responses.
The use rbonquial criteria for reversibility and obstruction to define patient groups for bronchodilator trials. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.
Role of bromhexine in exacerbations of bronchiectasis. Chronic bronchopulmonary diseases involving inflammation, hypersecretion and bronchial hyperreactivity, such as asthma, chronic bronchitis and chronic hipersecrecjon pulmonary disease COPD are common causes of medical consultation. Randomized code was open and the final sample distribution was: A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
hiperreactividad bronquial – English Translation – Word Magic Spanish-English Dictionary
Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: Acute additive effect of montelukast and beclomethasone on AMP induced bronchoconstriction. Effects of longterm use of macrolides in patients with non-cystic fibrosis bronchiectasis: The relationship of the bronchodilator response phenotype to poor asthma control in children with normal spirometry.
FEV1 response to bronchodilation in an adult urban population. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or brronquial suppurative lung disease Bronchiectasis Intervention Study: Phase 3 efficacy and safety data from randomized, multicentre study of liposomal amikacin for inhalation Arikace compared with Tobi R in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa.
Clinical interpretation of airway response to a bronchodilator: Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non cystic fibrosis bronchiectasis: Outcome measurements in COPD: EH, Koppers Hiperswcrecion, et al.
Asma Bronquial by Camila Tiznado on Prezi
Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Chhabra SK, Bhatnagar S. Response to isoproterenol in a general population sample. On days 0 and 90 the following evaluations were done: Cochrane Database Syst Rev.
Measurement of reversibility of airways obstruction: The disease-modifying effects of twiceweekly oral azithromycin in patients with bronchiectasis. Double-blind randomized multicenter study versus placebo. Pisi G, Chetta A.
Scheinberg P, Shore E. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I.
A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa.
Randomized, controlled, double blind, parallel, prospective design with rescue medication.
Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: However, users may print, download, or email articles for individual use. Criteria for the assessment of reversibility in airways obstruction. Hilersecrecion J Respir Dis Suppl.